Literature DB >> 25987821

Ferric citrate (auryxia) for the treatment of hyperphosphatemia.

Adam Pennoyer, Mary Barna Bridgeman.   

Abstract

Ferric citrate (Auryxia) for the treatment of hyperphosphatemia.

Entities:  

Year:  2015        PMID： 25987821      PMCID： PMC4422633     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  25 in total

1.  Ferric citrate controls phosphorus and delivers iron in patients on dialysis.

Authors:  Julia B Lewis; Mohammed Sika; Mark J Koury; Peale Chuang; Gerald Schulman; Mark T Smith; Frederick C Whittier; Douglas R Linfert; Claude M Galphin; Balaji P Athreya; A Kaldun Kaldun Nossuli; Ingrid J Chang; Samuel S Blumenthal; John Manley; Steven Zeig; Kotagal S Kant; Juan Jose Olivero; Tom Greene; Jamie P Dwyer
Journal:  J Am Soc Nephrol       Date:  2014-07-24       Impact factor: 10.121

Review 2.  Impact of kidney bone disease and its management on survival of patients on dialysis.

Authors:  Grace H Lee; Deborah Benner; Deborah L Regidor; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2007-01       Impact factor: 3.655

3.  Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis.

Authors:  Kausik Umanath; Mohammed Sika; Robert Niecestro; Carolyn Connelly; Gerald Schulman; Mark J Koury; Julia B Lewis; Jamie P Dwyer
Journal:  Hemodial Int       Date:  2012-06-15       Impact factor: 1.812

4.  Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Paul Muntner; Michal L Melamed; Caroline S Fox
Journal:  Nephrol Dial Transplant       Date:  2011-02-03       Impact factor: 5.992

5.  US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Yi Li; Bruce Robinson; John Ayanian; Rajesh Balkrishnan; Jennifer Bragg-Gresham; Joline T L Chen; Elizabeth Cope; Debbie Gipson; Kevin He; William Herman; Michael Heung; Richard A Hirth; Steven S Jacobsen; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Alan B Leichtman; Yee Lu; Miklos Z Molnar; Hal Morgenstern; Brahmajee Nallamothu; Ann M O'Hare; Ronald Pisoni; Brett Plattner; Friedrich K Port; Panduranga Rao; Connie M Rhee; Douglas E Schaubel; David T Selewski; Vahakn Shahinian; John J Sim; Peter Song; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Paul W Eggers; Lawrence Y C Agodoa; Kevin C Abbott
Journal:  Am J Kidney Dis       Date:  2015-07       Impact factor: 8.860

6.  The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients.

Authors:  Marvin Sinsakul; Mohammed Sika; Mark Koury; Warren Shapiro; Tom Greene; Jamie Dwyer; Mark Smith; Stephen Korbet; Julia Lewis
Journal:  Nephron Clin Pract       Date:  2012-10-16

7.  Phosphorus binders and survival on hemodialysis.

Authors:  Tamara Isakova; Orlando M Gutiérrez; Yuchiao Chang; Anand Shah; Hector Tamez; Kelsey Smith; Ravi Thadhani; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

8.  Serum phosphate and left ventricular hypertrophy in young adults: the coronary artery risk development in young adults study.

Authors:  Robert N Foley; Allan J Collins; Charles A Herzog; Areef Ishani; Philip A Kalra
Journal:  Kidney Blood Press Res       Date:  2009-02-20       Impact factor: 2.687

9.  Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.

Authors:  Jürgen Floege; Joseph Kim; Elizabeth Ireland; Charles Chazot; Tilman Drueke; Angel de Francisco; Florian Kronenberg; Daniele Marcelli; Jutta Passlick-Deetjen; Guntram Schernthaner; Bruno Fouqueray; David C Wheeler
Journal:  Nephrol Dial Transplant       Date:  2010-04-25       Impact factor: 5.992

10.  Ferric citrate hydrate as a phosphate binder and risk of aluminum toxicity.

Authors:  Ajay Gupta
Journal:  Pharmaceuticals (Basel)       Date:  2014-09-26
View more
  1 in total

1.  Cell-permeable iron inhibits vascular endothelial growth factor receptor-2 signaling and tumor angiogenesis.

Authors:  Devika Kir; Manju Saluja; Shrey Modi; Annapoorna Venkatachalam; Erica Schnettler; Sabita Roy; Sundaram Ramakrishnan
Journal:  Oncotarget       Date:  2016-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.